ATE117724T1 - Antibiotikum ge 22270, faktoren a1,a2,a3 und h. - Google Patents

Antibiotikum ge 22270, faktoren a1,a2,a3 und h.

Info

Publication number
ATE117724T1
ATE117724T1 AT90112547T AT90112547T ATE117724T1 AT E117724 T1 ATE117724 T1 AT E117724T1 AT 90112547 T AT90112547 T AT 90112547T AT 90112547 T AT90112547 T AT 90112547T AT E117724 T1 ATE117724 T1 AT E117724T1
Authority
AT
Austria
Prior art keywords
antibiotic
factors
medicaments
directed
treatment
Prior art date
Application number
AT90112547T
Other languages
English (en)
Inventor
Enrico Selva
Paolo Tavecchia
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit Spa filed Critical Lepetit Spa
Application granted granted Critical
Publication of ATE117724T1 publication Critical patent/ATE117724T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/02Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using fungi
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06139Dipeptides with the first amino acid being heterocyclic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Oncology (AREA)
  • Reproductive Health (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Endocrinology (AREA)
  • Communicable Diseases (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fodder In General (AREA)
AT90112547T 1989-07-04 1990-07-02 Antibiotikum ge 22270, faktoren a1,a2,a3 und h. ATE117724T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP89112171 1989-07-04

Publications (1)

Publication Number Publication Date
ATE117724T1 true ATE117724T1 (de) 1995-02-15

Family

ID=8201585

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90112547T ATE117724T1 (de) 1989-07-04 1990-07-02 Antibiotikum ge 22270, faktoren a1,a2,a3 und h.

Country Status (11)

Country Link
US (2) US5139778A (de)
EP (1) EP0406745B1 (de)
JP (1) JP2997510B2 (de)
KR (1) KR0165673B1 (de)
AT (1) ATE117724T1 (de)
CA (1) CA2020346C (de)
DE (1) DE69016284T2 (de)
DK (1) DK0406745T3 (de)
ES (1) ES2066914T3 (de)
GR (1) GR3015052T3 (de)
IE (1) IE67437B1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69016284T2 (de) * 1989-07-04 1995-05-24 Lepetit Spa Antibiotikum GE 22270, Faktoren A1,A2,A3 und H.
ES2071143T3 (es) * 1990-03-08 1995-06-16 Lepetit Spa Factores b1, b2, c1, c2, d1, d2, e y t del antibiotico ge 2270.
IL100572A (en) * 1991-01-03 1997-01-10 Lepetit Spa Amides of antibiotic ge 2270 factors their preparation and pharmaceutical compositions containing them
DK0529410T3 (da) * 1991-08-30 1998-05-11 Biosearch Italia Spa Antibiotikum GE 2270 faktor C2a
US5882900A (en) * 1992-09-10 1999-03-16 Gruppo Lepetit S.P.A. Process for the selective increase of production of antibiotic GE 2270 factor a by adding vitamin B12 to nutrient medium
WO1996024608A1 (en) 1995-02-07 1996-08-15 Biosearch Italia S.P.A. Basic oxazoline-amide derivatives of ge 2270 and ge 2270-like antibiotics
DE69600244T2 (de) * 1995-02-07 1998-10-01 Biosearch Italia Spa Basische prolinamid derivate von ge2270 und ge2270-ahnlichten antibiotika
ES2186866T3 (es) * 1996-02-14 2003-05-16 Biosearch Italia Spa Derivados de factores del antibiotico ge2270.
KR20050026401A (ko) * 2002-06-17 2005-03-15 비큐론 파마세티컬스 인코포레이티드 여드름 치료를 위한 ge 2270 인자 a3의 아미드유도체의 용도
AR060977A1 (es) * 2006-05-31 2008-07-23 Novartis Ag Aminotiazoles y sus usos
BRPI0720542A2 (pt) * 2006-12-20 2014-01-21 Novartis Ag Compostos antibacterianos e processos para a sua produção
EP2229386B1 (de) 2007-12-12 2015-06-03 Novartis AG Ein aminothiazol derivat und seine verwendung als antibakterieller wirkstoff

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4692333A (en) * 1982-08-26 1987-09-08 Gruppo Lepetit S.P.A. Antimicrobial and antitumor antibiotic M 9026 and its pure individual factors 1, 2, and 3 and microbial process for production thereof
GB8323382D0 (en) * 1983-08-31 1983-10-05 Lepetit Spa Antibiotic sb 22484
GB8333624D0 (en) * 1983-12-16 1984-01-25 Lepetit Spa Antibiotics l 17054 and l 17392
GB8821160D0 (en) * 1988-09-09 1988-10-12 Lepetit Spa Antibiotic ge 2270
DE69016284T2 (de) * 1989-07-04 1995-05-24 Lepetit Spa Antibiotikum GE 22270, Faktoren A1,A2,A3 und H.

Also Published As

Publication number Publication date
CA2020346A1 (en) 1991-01-05
IE902405A1 (en) 1991-06-19
ES2066914T3 (es) 1995-03-16
KR0165673B1 (ko) 1999-01-15
DE69016284T2 (de) 1995-05-24
JP2997510B2 (ja) 2000-01-11
DE69016284D1 (de) 1995-03-09
EP0406745A1 (de) 1991-01-09
KR910003107A (ko) 1991-02-26
CA2020346C (en) 2000-10-10
GR3015052T3 (en) 1995-05-31
JPH0363289A (ja) 1991-03-19
EP0406745B1 (de) 1995-01-25
US5547666A (en) 1996-08-20
IE67437B1 (en) 1996-04-03
DK0406745T3 (da) 1995-02-27
US5139778A (en) 1992-08-18

Similar Documents

Publication Publication Date Title
NO902800L (no) Fremgangsmaate for fremstilling av 11beta-aryl-4-oestrener.
DE3682767D1 (de) Antibiotika-a40926-n-acylaminoglycuronyl-aglykone und antibiotika-a40926-aglykone.
ATE117724T1 (de) Antibiotikum ge 22270, faktoren a1,a2,a3 und h.
ATE71113T1 (de) Antibiotikum a 40926 mannosyl aglycon.
DE69108972D1 (de) Antibiotika GE 2270 Faktoren B1, B2, C1, D1, D2, E und T.
ATE141605T1 (de) Thienotriazoldiazepinverbindungen und deren pharmazeutische anwendungen
ES2113391T3 (es) Factor c2a de antibiotico ge 2270.
ATE147757T1 (de) Propanolamin-cyclohexapeptide
ATE144780T1 (de) Megakaryocytopoietischer faktor
DE69317058D1 (de) Die antibiotika ge 37468 a, b und c
EP0359062A3 (de) Antibiotikum GE 2270
ATE173921T1 (de) Verwendung von deoxyspergualin zur herstellung eines arzneimittels zur behandlung von entzündlich-hyperreaktiven erkrankungen
FR2652086B1 (fr) Compose nouveau d'origine vegetale, derive de l'acide cafeique, l'oraposide; composition a usage therapeutique et composition dermato-cosmetique le contenant.
AU6725387A (en) Drugs for the treatment and cure of all infectious diseases caused by pathogenic virulent micro-organisms

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee